The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii

Afzal-Shah, 2001, Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii, Antimicrob Agents Chemother, 45, 583, 10.1128/AAC.45.2.583-588.2001

Andrews, 2005, BSAC standardized disc susceptibility testing method (version 4), J Antimicrob Chemother, 56, 60, 10.1093/jac/dki124

Bergogne-Bérézin, 1996, Acinetobacter spp. as nosocomial pathogens, microbiological, clinical, and epidemiological features, 9, 148, 10.1128/CMR.9.2.148

Brown, 2005, The sequences of seven class D beta-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents, Clin Microbiol Infect, 11, 326, 10.1111/j.1469-0691.2005.01096.x

Brown, 2005, Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina, Clin Microbiol Infect, 11, 15, 10.1111/j.1469-0691.2004.01016.x

Coelho, 2004, Spread of OXA-23-producing Acinetobacter baumannii clones in England, Clin Microbiol Infect, 10, 535

Corvec, 2003, AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains, J Antimicrob Chemother, 52, 629, 10.1093/jac/dkg407

Couture, 1992, Phylogeny of LCR-1 and OXA-5 with class A and class D β-lactamases, Mol Microbiol, 6, 1693, 10.1111/j.1365-2958.1992.tb00894.x

Dijkshoorn, 1996, Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods, J Clin Microbiol, 34, 1519, 10.1128/JCM.34.6.1519-1525.1996

Héritier, 2005, Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii, Antimicrob Agents Chemother, 49, 4174, 10.1128/AAC.49.10.4174-4179.2005

Poirel, 2005a, Genetic environment and expression of the extended-spectrum β-lactamase blaPER-1 gene in gram-negative bacteria, Antimicrob Agents Chemother, 49, 1708, 10.1128/AAC.49.5.1708-1713.2005

Poirel, 2005b, OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii, Antimicrob Agents Chemother, 49, 202, 10.1128/AAC.49.1.202-208.2005

Segal, 2004, Genetic environment and transcription of ampC in an Acinetobacter baumannii clinical isolate, Antimicrob Agents Chemother, 48, 612, 10.1128/AAC.48.2.612-614.2004

Segal, 2005, Is ISABA-1 customized for Acinetobacter?, FEMS Microbiol Lett, 243, 425, 10.1016/j.femsle.2005.01.005

Theaker, 2003, The impact of Acinetobacter baumannii in the intensive care unit, Anaesthesia, 58, 271, 10.1046/j.1365-2044.2003.30403.x

Turton, 2004, A prevalent, multiresistant, clone of Acinetobacter baumannii in South East England, J Hosp Infect, 58, 170, 10.1016/j.jhin.2004.05.011

Turton, 2005, Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom, J Clin Microbiol, 43, 3074, 10.1128/JCM.43.7.3074-3082.2005

Vaneechoutte, 1995, Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis, J Clin Microbiol, 33, 11, 10.1128/JCM.33.1.11-15.1995

Woodford, 2006, Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp, Int J Antimicrob Agents, 10.1016/j.ijantimicag.2006.01.004